CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Parabilis Medicines Inc. (PBLS) on Thursday reported a loss of $52.5 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of $2.32 per share. Losses, adjusted for non-recurring costs, were $2.13 per share.
The clinical stage pharmaceutical company posted revenue of $148,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBLS at https://www.zacks.com/ap/PBLS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
